These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 7775172

  • 1. Efficacy, safety, and tolerability of dihydroergotamine nasal spray as monotherapy in the treatment of acute migraine. Dihydroergotamine Nasal Spray Multicenter Investigators.
    Headache; 1995 Apr; 35(4):177-84. PubMed ID: 7775172
    [Abstract] [Full Text] [Related]

  • 2. Zolmitriptan 5 mg nasal spray: efficacy and onset of action in the acute treatment of migraine--results from phase 1 of the REALIZE Study.
    Gawel M, Aschoff J, May A, Charlesworth BR, REALIZE Study Team.
    Headache; 2005 Jan; 45(1):7-16. PubMed ID: 15663607
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A randomized, double blind, placebo-controlled study of MAP0004 in adult patients with migraine.
    Aurora SK, Rozen TD, Kori SH, Shrewsbury SB.
    Headache; 2009 Jun; 49(6):826-37. PubMed ID: 19545249
    [Abstract] [Full Text] [Related]

  • 7. [Treatment of migraine attacks: combination of dihydroergotamine tartrate and paracetamol in comparison with individual drugs and placebo].
    Hoernecke R, Doenicke A.
    Med Klin (Munich); 1993 Nov 15; 88(11):642-8. PubMed ID: 8295604
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Dihydroergotamine nasal spray for the acute treatment of migraine.
    Ziegler D, Ford R, Kriegler J, Gallagher RM, Peroutka S, Hammerstad J, Saper J, Hoffert M, Vogel B, Holtz N.
    Neurology; 1994 Mar 15; 44(3 Pt 1):447-53. PubMed ID: 8145914
    [Abstract] [Full Text] [Related]

  • 10. Sumatriptan nasal spray in adolescent migraineurs: a randomized, double-blind, placebo-controlled, acute study.
    Winner P, Rothner AD, Wooten JD, Webster C, Ames M.
    Headache; 2006 Feb 15; 46(2):212-22. PubMed ID: 16492230
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of sumatriptan tablets in migraineurs self-described or physician-diagnosed as having sinus headache: a randomized, double-blind, placebo-controlled study.
    Ishkanian G, Blumenthal H, Webster CJ, Richardson MS, Ames M.
    Clin Ther; 2007 Jan 15; 29(1):99-109. PubMed ID: 17379050
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Acute treatment of migraine with dihydroergotamine nasal spray. Dihydroergotamine Working Group.
    Gallagher RM.
    Arch Neurol; 1996 Dec 15; 53(12):1285-91. PubMed ID: 8970458
    [Abstract] [Full Text] [Related]

  • 14. Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study.
    Tepper SJ, Cady R, Dodick D, Freitag FG, Hutchinson SL, Twomey C, Kuhn TA.
    Headache; 2006 Jan 15; 46(1):115-24. PubMed ID: 16412159
    [Abstract] [Full Text] [Related]

  • 15. Symptomatic relief of migraine: multicenter comparison of Cafergot P-B, Cafergot, and placebo.
    Friedman AP, Di Serio FJ, Hwang DS.
    Clin Ther; 1989 Jan 15; 11(1):170-82. PubMed ID: 2497984
    [Abstract] [Full Text] [Related]

  • 16. Effect of pain intensity and time to administration on responsiveness to almotriptan: results from AXERT 12.5 mg Time Versus Intensity Migraine Study (AIMS).
    Freitag FG, Finlayson G, Rapoport AM, Elkind AH, Diamond ML, Unger JR, Fisher AC, Armstrong RB, Hulihan JF, Greenberg SJ, AIMS Investigators.
    Headache; 2007 Apr 15; 47(4):519-30. PubMed ID: 17445101
    [Abstract] [Full Text] [Related]

  • 17. MAP0004, orally inhaled DHE: a randomized, controlled study in the acute treatment of migraine.
    Aurora SK, Silberstein SD, Kori SH, Tepper SJ, Borland SW, Wang M, Dodick DW.
    Headache; 2011 Apr 15; 51(4):507-17. PubMed ID: 21457235
    [Abstract] [Full Text] [Related]

  • 18. Dihydroergotamine: role in the treatment of migraine.
    Schürks M.
    Expert Opin Drug Metab Toxicol; 2009 Sep 15; 5(9):1141-8. PubMed ID: 19624283
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Analgesic effects of intranasal butorphanol tartrate administered via a unit-dose device in the dental impaction pain model: a randomized, double-blind, placebo-controlled, parallel-group study.
    Wermeling DP, Grant GM, Lee A, Alexander N, Rudy AC.
    Clin Ther; 2005 Apr 15; 27(4):430-40. PubMed ID: 15922816
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.